Board of Directors

Jeffrey W. Dunn has served as the Chairman of our board of directors since our inception in April 2008. Mr. Dunn served as the CEO and President for 13 years from April 2008 until April 2021. Prior to co-founding SI-BONE, Mr. Dunn served as Chief Executive Officer of INBONE Technologies, Inc., an

Laura A. Francis has served as our Chief Executive Officer and a Director on our Board since April 2021. As our Chief Financial Officer since May 2015 and Chief Operating Officer since July 2019, Ms. Francis played a fundamental role in bringing the company public in October 2018 and building the

Timothy (Ted) E. Davis, Jr. has served as a member of our board of directors since our inception in April 2008. Mr. Davis joined BioTissue Holdings Inc. (fka BioTissue,Inc.),  a market leader in regenerative therapies for treating the ocular surface and other surgical indications, as President and

John G. Freund, M.D. has served as a member of our board of directors since January 2013. Dr. Freund founded Skyline Ventures, a venture capital firm, in October 1997 and has served as a Managing Director of Skyline since then. Prior to joining Skyline, Dr.

Jeryl Lynn Hilleman is a member of the Board of Directors. In addition to SI-BONE, Inc., her current board positions include public companies Novocure (Nasdaq: NVCR), HilleVax (Nasdaq: HLVX) and Minerva Neurosciences (Nasdaq: NERV) as well as private companies Omada Health, where she is Chair of

Gregory K. Hinckley has served as a member of our board of directors since January 2011. In 2017, Mr. Hinckley retired as president of Mentor Graphics Corporation, a leader in electronic design automation, after serving in that role for nearly 20 years. Prior to Mentor, Mr.

Mika Nishimura has nearly 30 years of experience in medical technology, serving in a variety of operational and executive capacities. Ms. Nishimura is currently an Operational Partner with Gilde Healthcare Partners, a life-science focused venture fund.

Thomas A. West has served as a member of our board of directors since June 2024. Since August 2022, Mr. West has served as President and Chief Executive Officer and as a member of the board of directors of Nalu Medical, Inc., a medical device company offering neurostimulation solutions for

Daniel (Dan) Wolf is senior vice president, chief strategy and M&A officer at Baxter International Inc.  Mr. Wolf joined Baxter in 2022 from Medtronic, where he most recently served as president of Medicrea and vice president and general manager, Intelligent Data Solutions.